Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Avoiding data pitfalls in clinical research

Genomics sequencing and sensors will present new challenges

- PMLiVE

CETP inhibitor class finally dies as Merck abandons anacetrapib

Cholesterol drug fails to “support regulatory filings”

- PMLiVE

NICE backs Pfizer’s Xeljanz for RA

But UK’s cost-effectiveness watchdog removes two drugs from CDF

- PMLiVE

After failing to repeal Obamacare, Trump tries another tack

US president signs executive order encouraging cheaper policies with fewer benefits

- PMLiVE

Sanofi appoints Stefan Oelrich to its executive team

He joins as executive vice president, diabetes and cardiovascular

Lilly strengthens team with in-house promotions

And two senior leaders retire

- PMLiVE

Building a bright future

Mylan takes a bold approach as it doubles its pipeline through R&D and acquisitions

- PMLiVE

A New Managing Director Appointed for Lighthouse Medical Communications US

Lucid Group boost their US operations with the appointment of Andy Willmer as Managing Director for Lighthouse Medical Communications

Lucid Group Communications Limited

- PMLiVE

Ferring appoints executive VP and chief medical officer

Professor Klaus Dugi joins the pharma group from Boehringer Ingelheim

- PMLiVE

Lundbeck and Otsuka start phase III for Rexulti in bipolar

Drug is also in phase II trial to treat PTSD patients

- PMLiVE

BMS appoints Saurabh Saha as senior VP, global head of translational medicine

He joins the R&D team from Atlas Venture

- PMLiVE

J&J files would-be prostate cancer blockbuster in US

Androgen receptor inhibitor achieves ‘significant’ MFS improvement over placebo

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links